Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma

NCT03761108 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

387

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Linvoseltamab

Sponsor

Regeneron Pharmaceuticals